Difficulty: Medium
Average Score: 89%
Practice
A 26-year-old G2P1001 woman at 33 weeks gestation presents to the emergency department with pain and swelling in her right calf. On physical examination, Homans sign is positive. A duplex of the right calf confirms the presence of a deep vein thrombosis (DVT). What is the most appropriate treatment for the rest of her pregnancy?
Correct answer
C
Rationale
In the case of a pregnant woman with a confirmed deep vein thrombosis (DVT), the most appropriate treatment for the rest of her pregnancy is option C: Heparin. Heparin is the anticoagulant of choice during pregnancy as it does not cross the placenta and is considered safe for both the mother and the fetus.
Option A, Abciximab, is a glycoprotein IIb/IIIa inhibitor primarily used in the management of acute coronary syndromes and during percutaneous coronary interventions. It is not indicated for the treatment of DVT in pregnancy.
Option B, Aspirin, is not the preferred anticoagulant for treating DVT during pregnancy as it is not as effective as heparin in preventing clot extension or embolization.
Option D, Streptokinase, is a thrombolytic agent used to dissolve blood clots in certain situations. However, it is contraindicated in pregnancy due to the risk of hemorrhage and other complications.
Educationally, understanding the choice of heparin in pregnancy for DVT treatment is crucial for healthcare providers managing pregnant patients with thrombotic disorders. It is essential to consider the safety and efficacy of anticoagulants in the context of pregnancy to optimize maternal and fetal outcomes.
Option A, Abciximab, is a glycoprotein IIb/IIIa inhibitor primarily used in the management of acute coronary syndromes and during percutaneous coronary interventions. It is not indicated for the treatment of DVT in pregnancy.
Option B, Aspirin, is not the preferred anticoagulant for treating DVT during pregnancy as it is not as effective as heparin in preventing clot extension or embolization.
Option D, Streptokinase, is a thrombolytic agent used to dissolve blood clots in certain situations. However, it is contraindicated in pregnancy due to the risk of hemorrhage and other complications.
Educationally, understanding the choice of heparin in pregnancy for DVT treatment is crucial for healthcare providers managing pregnant patients with thrombotic disorders. It is essential to consider the safety and efficacy of anticoagulants in the context of pregnancy to optimize maternal and fetal outcomes.